Literature DB >> 21494820

Cardiovascular risk factor assessments and health behaviours in patients using statins compared to a non-treated population.

Per Lytsy1, Gunilla Burell, Ragnar Westerling.   

Abstract

BACKGROUND: The perception of cardiovascular risk factors is believed to be associated with a person's willingness to carry out lifestyle changes as well as their willingness to adhere to prescribed preventive medications. Little is known about whether these perceptions differ between statin users and those not using statins, including how these factors relate to health behaviours.
PURPOSE: The objective was to investigate and compare the perceptions of known modifiable risk factors for cardiovascular disease in patients using statins with those of a non-treated population. One further objective was to investigate if statin use was associated with favourable health behaviours.
METHOD: Data about health, perception of the importance of cardiovascular risk factors and health behaviours were collected through questionnaires from 829 statin users and 629 non-statin users. Beliefs about risk factors were compared in univariate analyses, and four health behaviours were compared in multivariate regression models.
RESULTS: Statin users had better health behaviours in univariate analyses compared to non-statin users. Statin users rated lifestyle-related risk factors as more important contributors for the development of cardiovascular disease than non-statin users. In a multivariate model, statin use was associated with having better eating habits.
CONCLUSION: People using statins are more concerned about cardiovascular risk factors compared to non-statin users. The behaviour of taking statins seems to be associated with favourable eating habits.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 21494820     DOI: 10.1007/s12529-011-9157-6

Source DB:  PubMed          Journal:  Int J Behav Med        ISSN: 1070-5503


  13 in total

1.  Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III).

Authors: 
Journal:  JAMA       Date:  2001-05-16       Impact factor: 56.272

2.  Public perceptions of cardiovascular risk in five European countries: the react survey.

Authors:  L Erhardt; F D R Hobbs
Journal:  Int J Clin Pract       Date:  2002-11       Impact factor: 2.503

3.  European guidelines on cardiovascular disease prevention in clinical practice: full text. Fourth Joint Task Force of the European Society of Cardiology and other societies on cardiovascular disease prevention in clinical practice (constituted by representatives of nine societies and by invited experts).

Authors:  Ian Graham; Dan Atar; Knut Borch-Johnsen; Gudrun Boysen; Gunilla Burell; Renata Cifkova; Jean Dallongeville; Guy De Backer; Shah Ebrahim; Bjørn Gjelsvik; Christoph Herrmann-Lingen; Arno Hoes; Steve Humphries; Mike Knapton; Joep Perk; Silvia G Priori; Kalevi Pyorala; Zeljko Reiner; Luis Ruilope; Susana Sans-Menendez; Wilma Scholte Op Reimer; Peter Weissberg; David Wood; John Yarnell; Jose Luis Zamorano; Edmond Walma; Tony Fitzgerald; Marie Therese Cooney; Alexandra Dudina; Alec Vahanian; John Camm; Raffaele De Caterina; Veronica Dean; Kenneth Dickstein; Christian Funck-Brentano; Gerasimos Filippatos; Irene Hellemans; Steen Dalby Kristensen; Keith McGregor; Udo Sechtem; Sigmund Silber; Michal Tendera; Petr Widimsky; Jóse Luis Zamorano; Attila Altiner; Enzo Bonora; Paul N Durrington; Robert Fagard; Simona Giampaoli; Harry Hemingway; Jan Hakansson; Sverre Erik Kjeldsen; mogens Lytken Larsen; Giuseppe Mancia; Athanasios J Manolis; Kristina Orth-Gomer; Terje Pedersen; Mike Rayner; Lars Ryden; Mario Sammut; Neil Schneiderman; Anton F Stalenhoef; Lale Tokgözoglu; Olov Wiklund; Antonis Zampelas
Journal:  Eur J Cardiovasc Prev Rehabil       Date:  2007-09

4.  Risk homeostasis theory: an overview.

Authors:  G J Wilde
Journal:  Inj Prev       Date:  1998-06       Impact factor: 2.399

5.  Comparison of risk perceptions and beliefs across common chronic diseases.

Authors:  Catharine Wang; Suzanne M O'Neill; Nan Rothrock; Robert Gramling; Ananda Sen; Louise S Acheson; Wendy S Rubinstein; Donald E Nease; Mack T Ruffin
Journal:  Prev Med       Date:  2008-11-25       Impact factor: 4.018

6.  Psychosocial distress and impaired quality of life--targets neglected in the secondary prevention in women with ischaemic heart disease.

Authors:  Maria Claesson; Gunilla Burell; Lisbeth Slunga Birgander; Bernt Lindahl; Kjell Asplund
Journal:  Eur J Cardiovasc Prev Rehabil       Date:  2003-08

7.  The From The Heart study: a global survey of patient understanding of cholesterol management and cardiovascular risk, and physician-patient communication.

Authors:  F D Richard Hobbs; Leif R Erhardt; Catherine Rycroft
Journal:  Curr Med Res Opin       Date:  2008-03-19       Impact factor: 2.580

8.  Illness beliefs about heart disease and adherence to secondary prevention regimens.

Authors:  Lesley Stafford; Henry J Jackson; Michael Berk
Journal:  Psychosom Med       Date:  2008-10-08       Impact factor: 4.312

9.  Risk compensation and vaccination: can getting vaccinated cause people to engage in risky behaviors?

Authors:  Noel T Brewer; Cara L Cuite; James E Herrington; Neil D Weinstein
Journal:  Ann Behav Med       Date:  2007-08

10.  Perception of cardiovascular risk and comparison with actual cardiovascular risk.

Authors:  Heba Alwan; Julita William; Bharahti Viswanathan; Fred Paccaud; Pascal Bovet
Journal:  Eur J Cardiovasc Prev Rehabil       Date:  2009-10
View more
  9 in total

1.  Different time trends of caloric and fat intake between statin users and nonusers among US adults: gluttony in the time of statins?

Authors:  Takehiro Sugiyama; Yusuke Tsugawa; Chi-Hong Tseng; Yasuki Kobayashi; Martin F Shapiro
Journal:  JAMA Intern Med       Date:  2014-07       Impact factor: 21.873

2.  Tailored interventions by community pharmacists and general practitioners improve adherence to statins in a Spanish randomized controlled trial.

Authors:  Ainhoa Oñatibia-Astibia; Amaia Malet-Larrea; Belen Larrañaga; Miguel Ángel Gastelurrutia; Begoña Calvo; Dulce Ramírez; Ignacio Cantero; Ángel Garay; Estibaliz Goyenechea
Journal:  Health Serv Res       Date:  2019-04-07       Impact factor: 3.402

Review 3.  A point-by-point response to recent arguments against the use of statins in primary prevention: this statement is endorsed by the American Society for Preventive Cardiology.

Authors:  Parag H Joshi; Sameer Chaudhari; Michael J Blaha; Steven R Jones; Seth S Martin; Wendy S Post; Christopher P Cannon; Gregg C Fonarow; Nathan D Wong; Ezra Amsterdam; John W Hirshfeld; Roger S Blumenthal
Journal:  Clin Cardiol       Date:  2012-06-06       Impact factor: 2.882

4.  Decreasing cholesterol levels in the community--lifestyle change with statin?

Authors:  Jorma Savolainen; Hannu Kautiainen; Leo Niskanen; Pekka Mäntyselkä
Journal:  BMC Fam Pract       Date:  2015-02-28       Impact factor: 2.497

5.  A content analysis of the representation of statins in the British newsprint media.

Authors:  Julia Chisnell; Tom Marshall; Chris Hyde; Zhivko Zhelev; Lora E Fleming
Journal:  BMJ Open       Date:  2017-08-21       Impact factor: 2.692

6.  Association between Dietary Intake and Lipid-Lowering Therapy: Prospective Analysis of Data from Australian Diabetes, Obesity, and Lifestyle Study (AusDiab) Using a Quantile Regression Approach.

Authors:  Adelle M Gadowski; Natalie Nanayakkara; Stephane Heritier; Dianna J Magliano; Jonathan E Shaw; Andrea J Curtis; Sophia Zoungas; Alice J Owen
Journal:  Nutrients       Date:  2019-08-09       Impact factor: 5.717

7.  Lifestyle Changes in Relation to Initiation of Antihypertensive and Lipid-Lowering Medication: A Cohort Study.

Authors:  Maarit J Korhonen; Jaana Pentti; Juha Hartikainen; Jenni Ilomäki; Soko Setoguchi; Danny Liew; Mika Kivimäki; Jussi Vahtera
Journal:  J Am Heart Assoc       Date:  2020-02-05       Impact factor: 5.501

8.  Comparing the Trend of Physical Activity and Caloric Intake between Lipid-Lowering Drug Users and Nonusers among Adults with Dyslipidemia: Korean National Health and Nutrition Examination Surveys (2010-2013).

Authors:  Jin-Young Oh; Lan Chekal; Se-Won Kim; Jee-Yon Lee; Duk-Chul Lee
Journal:  Korean J Fam Med       Date:  2016-03-25

9.  Comparison of Food and Nutrient Intakes between Japanese Dyslipidemic Patients with and without Low-Density Lipoprotein Cholesterol Lowering Drug Therapy: A Cross-Sectional Study.

Authors:  Noriko Kameyama; Chizuko Maruyama; Yuri Shijo; Ariko Umezawa; Aisa Sato; Makoto Ayaori; Katsunori Ikewaki; Masako Waki; Tamio Teramoto
Journal:  J Atheroscler Thromb       Date:  2019-10-03       Impact factor: 4.928

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.